Literature DB >> 21468293

Setting up a Death Row Psychiatry Program.

Jason Yanofski1.   

Abstract

Death row psychiatry contains a complex set of clinical, ethical, and legal questions. This Forensic Files column makes a case for correctional institutions starting death row programs to address these issues through uniform policies. A list of the relevant issues is provided. Specific issues discussed include death row psychiatric assessment, considering "justifiable" depression, treating for competency to be executed, and balancing boundaries between clinical and forensic work.

Entities:  

Keywords:  Forensic psychiatry; competency; correctional psychiatry; death penalty; mood disorders

Year:  2011        PMID: 21468293      PMCID: PMC3071089     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  6 in total

1.  Prisoners v. Prisons: A History of Correctional Mental Health Rights.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-10

2.  On wearing two hats: role conflict in serving as both psychotherapist and expert witness.

Authors:  L H Strasburger; T G Gutheil; A Brodsky
Journal:  Am J Psychiatry       Date:  1997-04       Impact factor: 18.112

Review 3.  Psychiatry and the death penalty: dilemma for mental health professionals.

Authors:  E J Kermani; S L Drob
Journal:  Psychiatr Q       Date:  1988

4.  Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community.

Authors:  Renee D Goodwin; Steven P Hamilton
Journal:  Psychiatry Res       Date:  2003-02-15       Impact factor: 3.222

5.  Psychopathological effects of solitary confinement.

Authors:  S Grassian
Journal:  Am J Psychiatry       Date:  1983-11       Impact factor: 18.112

6.  'Justifiable depression': how primary care professionals and patients view late-life depression? A qualitative study.

Authors:  Heather Burroughs; Karina Lovell; Mike Morley; Robert Baldwin; Alistair Burns; Carolyn Chew-Graham
Journal:  Fam Pract       Date:  2006-02-13       Impact factor: 2.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.